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Introduction n
Inn response to viral infection, naive CD8*, MHC class l-restricted, virus-specific T cells expandd clonally and differentiate into effector cells that eliminate or neutralize the virus and memoryy cells that provide enhanced immunity on re-infection [1] [2] [3] . CD8 + T cells are the primaryy mechanism of the adaptive immune system to cope with the many viral diseases that aree encountered during a lifetime, many of which occur during childhood. A better understandingg of virus-induced CD8 + T cell development and functional properties of the respectivee CD8 + T cell subpopulations will thus be of great meaning to clinical diagnostics in virall disease. Functionallyy distinct CD8 + T cell subsets can be distinguished by use of combinations of phenotypicc markers such as CD45RA/CD45R0, the costimulatory receptors CD28 [4] , CD27 [5] ,, and the chemokine receptor CCR7 [6] . Naïve CD8 + T cells express CD45RA (but not CD45R0)) as well as CD27, CD28 and CCR7. Viral infection induces a massive expansion of specificc CD8 + cells and rapid up-regulation of the cytolytic molecules perforin and granzyme BB [7] . During acute infection these cells express CD45R0, CD38 and HLA-DR, CD27 and CD28,, whereas later in infection CD27 and CD28 may become down-regulated [8] . In healthy individuals,, two prevalent types of resting primed (memory) T cells can be discerned. CD45R0 + CD28 + CD27 ++ T cells that have the ability to secrete IL-2, IFN-y, TNF-a, and IL-4 andd contain virus-specific CTL precursors [9] . A second primed population can be characterizedd by CD45RA expression with concomitant absence of the costimulatory moleculess CD27 and CD28 and of CCR7. This CD8 + CD45RA + CD27" population can secrete IFN-yy and TNF-a but not IL-2 or IL-4, abundantly expresses CD95-ligand, perforin, granzyme B,, and shows high cytolytic activity without in vitro prestimulation [10] . In healthy individuals, aa high degree of variation in the subset composition of the circulating CD8* T-cell population iss observed. Although the way in which this variability is generated is unknown, recent studiess have suggested that particular viruses may preferentially be associated with certain phenotypess of virus-specific T cells in latency [11] . 30 0 CD8 ++ T-cell subsets and viral infection Too directly address this question, the relationship between CD8* T-cell subset composition andd common viral infections during childhood, i.e., EBV, CMV, varicella-zoster virus (VZV), andd measles-mumps-rubella (MMR) vaccinations was studied. Both EBV and CMV are herpesvirusess that infect the vast majority of humans, following a bimodal pattern of infection withh peaks during early childhood and late adolescence, being defined to a large extent by socio-economicc factors [12, 13] . In the Netherlands, a cross-sectional serum study performed inn 1991 had shown that 40% is EBV-seropositive at 10 years of age increasing to 98% at 30 years,, while CMV immunity is detected in -30% and -50%, respectively [14] . Infection with thesee viruses early in life is most often asymptomatic, while infection later in life is a selflimitingg disease more often associated with clinical symptoms [12] . On the other hand, chickenpoxx (varicella) is a common disease during childhood, caused by primary infection withh VZV, a highly contagious herpesvirus with attack rates of >85% in susceptible contacts inn the temperate climate under 7 years of age [15] [16] [17] . Varicella vaccine is not presently in usee in The Netherlands. However, live attenuated measles, mumps, and rubella virus are usedd for routine MMR vaccination in The Netherlands with a coverage of >98% of the young childrenn and high seroconversion rates regardless of intercurrent infections or fever [18] [19] [20] [21] [22] . Ourr analyses show that CMV is the main, if not only, factor responsible for the expansion of cytolyticc CD8 + CD45RA + CD27" T cells.
Materialss and Methods

StudyStudy design
Childrenn and young adolescents under the age of 18 being routinely analyzed for pre-or peri-operative proceduress were included in the study (n-220; control cohort; Table 1 ). We also included patients with aa diagnosis of a (sub) acute viral infection and those tested or admitted for a suspected viral infection off the upper and lower respiratory, gastrointestinal, or urogenital tract (n=58). Those with an acute CMVV infection were asked for consent to be followed-up with regular blood tests (n=16). In 10 families alll members who underwent venipuncture for HLA-typing in a search for an HLA-identical family donor forr a related sibling (not included in the pedigrees) were also tested for viral serology against various commonn viruses after written consent was obtained. Data for infants under the age of 6 months were nott included to avoid the interference of (low titer) maternal Abs in our study. In each age category -15-30%% of the healthy controls were of African, Caribbean, or Mediterranean origin. The remainder weree of Caucasian origin. Informed consent for the research purpose described was obtained from the parentss of the children included in the studies as approved by the institutional medical ethical committee. . Inn addition, a pediatric cohort of 21 renal transplant patients was prospectively followed. Immunosuppressivee medication consisted of prednisone (7.5 mg/m 2 ), cyclosporin (plasma trough range,, 100-150 ng/ml), and either azathioprine (1-2 mg/kg), or myeophenolate mofetil (1.2 g/m 2 /day in twoo doses). Immunophenotypingg of PBMC fractions from the blood from individuals was performed as described below.. In the same blood samples, T cell proliferation tests were performed to define functional activity inin vitro and thus exclude unforeseen immune dysfunction. Serology was performed in blood obtained att the same moment as the immune tests.
LaboratoryLaboratory tests for EBV, CMV, VZV and MMR serology
Specificc IgM and IgG against the EBV-viral capsid Ag was determined by indirect immunofluorescence andd Abs to Epstein-Barr nucleic acid by anticomplement immunofluorescence (Gull Laboratories, Salt Lakee City, UT). Specific IgG Abs to CMV and rubellavirus were defined by Imx assays (Abbott Diagnostics,, Amstelveen, The Netherlands). IgM to CMV and IgG to VZV were defined by VIDAS tests (Biomerieux,, Lyon, France). Specific IgG to measles and mumps was defined by ELISA (Virotech, Russelheim,, Germany). All tests were performed following the instructions of the manufacturers. Serologyy data for EBV, CMV, VZV, measles, mumps, and rubella in the control individuals are summarizedd in Table 1 . The serologic characteristics of the cohort are in agreement with previous studiess [14] .
LymphocyteLymphocyte subsets and enumeration of cytolytic effector cells
Thee numbers of B cells (CD19 + ), T cell (CD2\ CD3 + , CD4\ CD8 + ) subsets, and NK cells (CD2 + /CD3~, CD16 + ,, CD56 + ) were determined by standard FACScan procedures with mAbs being produced by CLBB (Amsterdam, The Netherlands). For determination of subpopulations within the CD8 + T cell fraction,, FITC-and PerCP-conjugated CD3, CD8, and CD27 were all purchased from BD Biosciences (Sann Jose, CA). CD45RA-PE was obtained from Coulter Immunology (Hialeah, FL). Biotinylated CD27 wass manufactured at CLB. Using these mAbs for triple staining, gating on CD8 + lymphocytes allowed furtherr subtyping into naive resting cells (CD45RA + CD27 + ) and functional distinct subsets of primed cells,, i.e., noncytolytic CD45RA"CD27 + (memory-type) and cytolytic CD45RA + CD27" T cells (effectortype),, as extensively characterized previously [6, 7] . TheThe first age category comprises controls from 6-12 months only, to exclude interferenceinterference of maternal Ab as much as possible. The categories consist of 2-year groups fromfrom the age of 8 years, apart from the category >18 years. bb The number tested per age category was always >80% of the total number of controls includedincluded in each category. cc MMR compi, complete seroconversion for all three MMR vaccine components, determineddetermined as IgG positivity above the standard cut-off levels for the three different components'components' test Ag. Incomplete MMR seroconversion against one or two viral Ag was detecteddetected in 8% of the cases; these were considered negative in the calculations shown.
TableTable 1 Seropositivity as percentage of age in the controls tested
GenerationGeneration of HLA-A2.1/CMVpp65 (NLVPMVATV ) and HLA-B7/CMVPP65 (TPR VTGGGAW tetrameric complexes Tetramericc complexes were generated essentially as described by Altman et al. [23] . In brief, purified HLA-A2.11 and HLA-B7 heavy chains and p 2 microglobulin were synthesized using a prokaryotic expressionn system (pET; Novagen, Milwaukee, Wl). The heavy chains were modified by deletion of thee transmembrane/cytosolic tail and COOH-terminal addition of a sequence containing the BirA enzymaticc biotinylation site. The HLA-A2.1 binding CMV pp65-derived peptide NLVPMVATV and the HLA-B77 binding CMV pp65-derived peptide TPRVTGGGAM were used for refolding. The refolded productss were isolated using HPLC, biotinylated by BirA (expressed using the pET expression system, purifiedd using cobalt beads (Clontech, Palo Alto, CA)) in the presence of biotin (Molecular Probes, Eugene,, OR), ATP (Sigma-Aldrich, St. Louis, MO) and MgCI. The biotinylated products were separatedd from free biotin by gel filtration using HPLC [24] . Streptavidin-PE or streptavidinallophycocyaninn conjugate (Molecular Probes) was added in a 1/4 molar ratio.
ImmunofluorescentImmunofluorescent staining and fiowcytometry
Freshlyy isolated or thawed PBMCs were resuspended in RPMI containing 10% FCS and antibiotics. PBMCss (n=200,000) were incubated with fluorescent label-conjugated mAbs (concentrations in accordancee with manufacturer's instructions) and an appropriate concentration of tetrameric complexess in a small volume for 30 min at , protected from light. Cells were washed in PBS containingg 0.01% (w/v) NaN 3 and 0.5% (w/v) BSA. Analyses consisted of allophycocyanin-conjugated tetramerss and CD8-PerCP in combinations with CD45RA-FITC and CD27-PE (all BD Biosciences). Analysiss of cells for the expression of cell surface markers was performed using a FACSCalibur flow cytometerr and CellQuest software (BD Biosciences).
Statistics Statistics
Student'ss f test and ANOVA were applied for normally distributed data, and the Wilcoxon two-sample testt and the Kruskal-Wallis test were used for nonnormalty distributed data. Fisher's exact test was usedd for statistical analysis of symptoms in the cohorts of controls and patients.
Results s
FrequenciesFrequencies of cytolytic CD8*CD45RA*CD27~ T cells correlate to prior CMV infection
Cohortss of patients are often compared with historic and/or presumably healthy controls, disregardingg the potential impact of their infectious history. An additional problem arises becausee of the differences in lymphocyte numbers and lymphocyte subset distribution dependingg on age [25, 26] . We performed an extensive immunophenotyping of PBMCs from healthyy children to define normal levels of predefined CD4* and CD8 + T-cell subpopulations inn various age cohorts. In most of the children, serology (IgM and IgG) against EBV, CMV, VZV,, and MMR was simultaneously performed. In this way, we had the opportunity to analyzee the relation between viral infections and immunization in the past, on the one hand, andd the number of T cell subsets, on the other. Abs.. no. of CD8 + CD45RA*CD2r T cells 0.728 0.144 -0.055 -0.060 dividedd by total no. of CD3* T cells (P< 0.005) SerumSerum responses were positive or negative according to the standard cut-off values described in "Materials"Materials and Methods" for the various serology tests applied in accordance with the manufacturer's instructions.instructions. The qualitative seroreactivity was con-elated to the quantitative number of cytotoxic T cells.cells. The CD45RA* CD2T cells were considered as the percentage of total CD8* T cells, as an absoluteabsolute cell number (percentage x 0.01 x absolute CD8* T cell count x 1000/ml), or as this absolute CD8*CD8* CD45RA* CD2T celt count divided by the absolute number of total CD3* T cells. bb See note 3 of the legend of Table 1 . Incomplete MMR seroconversion against 1 or 2 viral antigens waswas detected in 8% of the cases; these were considered negative in the calculations shown. When the partiallypartially incomplete seroconversion samples were considered seropositive instead, the result was still notnot significant in the calculation of the correlation coefficient (not shown).
TableTable 2 Correlation coefficients of seropositivity for various viruses with the CD8*CD45RA*CD27-CD8*CD45RA*CD27-T cells in all healthy controls tested
Absolutee numbers of CD3* lymphocytes, CD3 (CD16 + CD56 + ) NK cells, CD4 + CD45RA + and CD4 + CD45R0** T cells did not show a correlation of any kind with the serology findings againstt the viruses tested. However, a highly significant correlation was found between the percentagee as well as the absolute number of circulating CD8 + CD45RA + CD27" cytolytic T cellss and CMV seropositivity in healthy individuals ( Table 2) . Representative histograms of a CMV-seronegativee and an age-matched CMV-seropositive individual (left and right panels, respectively)) are shown in Fig. 1 . Ass expected, the CMV-seropositive and CMV-seronegative population differed in age (Table   3) ,, but not in gender or racial background (data not shown). Moreover, the percentage and absolutee number of CD45RA + CD27" cells within the CD8 + T cell fraction were different betweenn the two groups. To avoid the impact of background staining variability in routine immunophenotypingg procedures, the cut-off for a positive result in the number of CD8 + CD45RA + CD27~~ T cells was set at 0.02x10 6 /ml blood as a minimum. Absolute cell countss above that number strongly correlate to prior CMV infection (odds ratio, 229.5; 95% confidencee interval: 69.6-757.2; see Table 3 ). When arbitrarily set at 0.01 x10 6 cells/ml, absolutee numbers of cytolytic CD8 + T cells remained highly predictive (odds ratio, 81.2; 95% confidencee interval, 18.9-348.7). The number of CD8 + CD45RA + CD27~ T cells remained surprisinglyy constant over a period of 2-4 years in a series of 40 controls who were checked att a regular base for other than infectious reasons (data not shown). MeanMean in years is in parentheses.
TableTable 3 CMV status in relation to the number of CD8*CD45RA*CD27~ T cells
CD8** T-cell subsets and viral infection
CD8*CD45RA*CD27~CD8*CD45RA*CD27~ T cells rise during acute CMV infection
Childrenn without a known immune disorder of any kind who came to our attention because of acutee CMV disease (n=16) were studied. From two patients, blood samples were available fromm a time point before the start of CMV disease ( Fig. 2 B and C) . Acute disease was definedd by positive cultures, CMV IgM serology, and, when performed, the presence of CMV DNAA in whole blood as detected by a quantitative PCR technique [27] . A progressive rise in CD8 + CD45RA + CD27~~ T cell numbers was observed starting within 3-4 weeks after diagnosis, whichh is in agreement with our recent observations in adult patients receiving allo-kidney grafts.. Within 2 months a plateau was reached, with stable numbers of CD8 + CD45F<A + CD27"
TT cells for the following months of follow-up ( Fig. 2 A- 
FigureFigure 2 Increase in CD8*CD45RA*CD2T T cells after primary CMV infection, as shown for threethree separate individuals. The absolute numbers (10 6 /ml) of CD8* T cells (m) and CD8*CD8* CD45RA* CD2T T cells (a) are compared with the CMV DNA concentration expressed as copies perper milliliter of whole blood Patient A was an infant treated with gancyclovir because of respiratory failurefailure due to CMV pneumonitis; patients B and C were an untreated infant and young child with symptomssymptoms of vomiting and a temporary growth failure due to CMV-hepatitis. Time zero represents retrospectivelyretrospectively defined blood samples, once collected and preserved for other reasons. Data are representativerepresentative for 16 patients in total.
Too investigate the phenotype of CD8 + T cells with confirmed CMV specificity, studies with CMV-specificc tetramers were performed. On 50 blindly selected healthy individuals in our study,, HLA-genotyping was performed regardless of the CMV serology or number of CD8 + CD45F?A + CD27~~ T cells. From these blindly selected individuals, 23 were CMV seropositive,, and 27 CMV seronegative at that time. HLA-A2 and/or HLA-B7 were present uponn HLA-typing in seven individuals with prior CMV infection, as defined by positive anti-CMVV IgG titers. False-positive findings of CMV-specific tetramer binding to HLA-A2 + and/or -B7 ++ T cells were not observed in the absence of prior CMV infection (0 of 22), or vice versa in thee case of prior CMV-infection but absence of the correct HLA-A2 and/or B7-haplotype (0 of 16).. In agreement with previous findings [28, 29] , tetramer-positive, CMV-specific cells were neverr detected in the naive (CD45RA + CD27 bri9ht ) subset of CD8 + T cells ( Fig. 3 A and B) .
Enrichmentt of CMV peptide-specific T cells was particularly observed in the CD27" pool of CD8 ++ T cells as well as in the CD27 du " fraction ( Fig. 3B) [8, 11] . The percentage of tetramerpositivee T cells ranged from 0.8-4.9 % of total CD8 + T cells. It is likely that the Ag specificity withinn the pre-activated CD27" cytolytic cell fraction is much broader than to the single CMV peptidee tested. Coinciding with the increase in pre-activated CD8 + CD45RA + CD27" T cells, we observedd a rapid appearance of the CMV-specific CD8 + T cells in an HLA-A2* child with acutee CMV hepatitis. These CMV-tetramer positive CD8 + T cells progressively increased beforee stabilization over a period of 12 months of follow-up ( Fig. 3C) . 
FigureFigure 3 Tetramer staining of CMV peptide-specific CD8* T cells. Tetramer-positive cells were detecteddetected in CD8* T cells as a distinct set of T cells (A), primarily detected within the CD27-dull ornegativenegative CD8* T cell subset (B) (total CD8* T cells plotted in gray, and CMV-specific CD8* T cells plottedplotted in black). The time course in acute CMV disease is shown for a 2-year-old HLA-A2* girl tested forfor CMV-specific T cells and number of CD8* CD45RA* CD2T T cells. (C) The absolute numbers (10(10 ee /ml)/ml) of CD8* T cells (m) and CD8* CD45RA* CD2T T cells (u) are compared with the percentage of tetramer-positivetetramer-positive (tet*) CD8* T cells (k).
IndividualIndividual set-point in the formation of CD8*CD45RA*CD27', cytolytic T cells: family segregation? segregation?
AA genetic correlation with the absolute number of CD4 + and CD8 + T cells has been previously documentedd [30] . The number at which a person's CD8 + cytolytic T cells stabilize was investigated.. Ten family pedigrees were tested for a pattern of segregation and gene inheritancee (HLA class I and class II typing). As shown for three representative families ( Fig.   4 ,, A-C), the presence of CD8 + CD45RA + CD27" T cells was unrelated to any of the viruses testedd other than CMV, without a pattern of parental HLA haplotype inheritance (data not shown).. Offspring from parents with high numbers of these cytolytic cells did not all show highh numbers (Fig. 4B ). Vice versa, children with high CD8 + CD45RA + CD27" T cell numbers cann have parents with low cytolytic T cell numbers (Fig. 4C) . In some families one of the parentss (mostly fathers (Fig. 4B and C) ; rarely mothers (Fig. 4A) ) was still CMV seronegative andd did not have cytotoxic CD8 + T cells, whereas his/her partner and children showed positivee reactivity. 
IndividualIndividual set-point of CD8*CD45RA*CD27~ T cells: a matter of immune competence ?
Thee set-point of CD8 + CD45RA + CD27" T cells was only weakly related to age, whereas clinicall symptoms during CMV infection, prior viral infections, racial background, and sex did nott show any relation to the set-point (data not shown). When the two groups most separated inn age were compared, a more direct age effect seemed apparent. Young children (age, 0-4 years;; n=23) and young adolescents {age, 15-18; n=23 ) differed significantly in number and percentagee of CD8 + cytolytic T cells, also when the increased absolute number of CD8 + T cellss at young age was taken into account (Table 4) . Immunosuppressedd renal transplant patients who were infected with CMV after transplantationn had significantly higher CD8 + CD45RA + CD27~ T cell numbers than those who weree CMV IgG-positive before transplantation or non-immunosuppressed, age-matched controlss (for whom we do not know at which age CMV was contracted; Fig. 5 ). 
Discussion n
Extensivee T cell phenotyping has become common practice as a relevant immuno-diagnostic tool.. Previously, our group ascribed direct ex vivo cytotoxicity to a defined subset of CD8 + CD45RA + CD27~~ T cells, which, without prior activation, express not only perforin and granzyme,, but also CD95 ligand [5, 10] , We tested >200 healthy children for T cell subset distributionss in relation to the serologic proof of acute or past infection with CMV, EBV, or VZVV or immunization with attenuated MMR strains. The presence of cytolytic CD8 + CD45RA + CD2rr T cells strongly correlated to CMV infection (p < 0.000001), but importantlyy not with other viruses (Table 2) . Thee role of CMV in the selective expansion of particular CD8 + T cell subsets had been suggestedd [18, 31, 32] ; however, further phenotypic (apart from CD57) and functional characterizationn is lacking [31, 32] . Moreover, the studies were performed in small cohorts of patientss without long-term follow-up. It is unclear whether CD8 + CD57 + T cells represent a uniquee and homogeneous subset with distinct functions. Using CD8 + T cells isolated from patientss at various times after allogeneic bone marrow transplantation, high numbers of CD8 + CD57 ++ T cells correlated to diminished killing of CMV-infected targets [33] . Such a reducedd cytotoxic capacity would support a functional relationship between immune competencee (age, immunosuppression) and the number of CD8 + CD45RA + CD27" cytolytic T cellss (Fig. 5 ), of which most coexpress CD57 [9] . In allogeneic transplants CD8 + CD57 + T effectorr cells did not produce any TNF-oc or IFN-y after anti-CD3 stimulation [33] , whereas isolatedd CD8 + CD45RA + CD27" T cells from healthy controls did [5] . Moreover, the vast majorityy of resting CD8 + T cells capable of rapid induction of TNF-oc and IFN-y synthesis in responsee to CMV peptides were found in a subset with intermediate to high expression of CD57,, low CD27, and reversal of the classical memory CD45R0 to the CD45RA phenotype [34] .. This subpopulation probably includes the fully differentiated effector-type cells responsiblee for long term suppression of the virus and avoidance of disease from CMV reactivation.. Using tetramer staining we found that these cells are generated at a relatively shortt time (2 months) after primary CMV infection in children (Fig. 3C ). Ass we now demonstrate, CMV infection is the major trigger for the selective expansion of the CD8 + CD45RA + CD27~~ T cell subset to an individual set-point at which the number of these CD8 ++ T cells stabilizes for the following years ( Fig. 2 and 3 ). Of the various factors studied (suchh as race, sex, inheritance, coinfections (prior EBV, VZV, or MMR)), young age or immunosuppressionn at the onset of acute CMV infection determines to a large extent this individuall set-point. An independent genetic impact on the number of T cells has been suggestedd [30] . Yet, an inherited set-point for CD8 + cytolytic T cells after CMV infection was nott supported by a study in 10 families, although the confounding factor age at onset of CMV infectionn was unknown for the families tested. Speculationss can be made about development of the cytotoxic CD8 + T cell subset. Although CD8 + CD45RA + CD27~~ T cells are detected in all CMV-infected individuals, their numbers increasee in clinical situations of immunosuppression ( Fig. 5 ) [11] . In immunosuppressed patients,, CMV reactivation could still occur under relatively normal conditions (here evaluated byy CD4 + T cell number and proliferation tests) during follow-up, allowing adaptive responses off the CD8* T cell subsets to increased levels of viral antigen. Possibly CMV antigen not only inducess further expansion of virus-specific cells, but also their development into CD8 + CD45RA + CD27"" T cells [28] . The bulk of fully differentiated CD8 + T effector-type cells may,, in fact, be different in specificity or binding avidity from the most potent cytotoxic T cells generatedd during CMV infection. CMV immunity in humans is focussed on two immunodominantt proteins, i.e., pp65 and, to a lesser extent, IE1 [35] . Using the pp65 peptide-containingg tetramer to detect CMV-specific T cells, we found that most of the CMVtetramerr positive cells (50-60%) were present in the CD8 + CD45RA + CD27~ T cell fraction, representingg <10% of the total CD8 + CD45RA + CD27~ T cells (data not shown). Confirming dataa from adults [11] , EBV-tetramer-positive cells (80-90%) predominated in CD45R0 + CD27 + (memory-type)) CD8 + T cell fraction (not shown). The restriction of EBV-and HlV-derived peptide-specificc CD8 + T cells in adult patients to this type may very well represent a normal phenomenonn [29] . Thee use of tetramers has, in just 4 years, transformed our understanding of the immune responsess against HIV, human T lymphotropic virus 1, hepatitis B and C virus, CMV, and EBV,, and holds promise in a number of areas where quantitative analysis of the antiviral responsee in terms of both number and function is critical. Nevertheless, the technique remainss limited in terms of suitability of the HLA background as well as availability of reagentss to cover a more complete spectrum of protein-derived peptides involved in immunity.. These techniques, however, leave open the question by which mechanism or protein(s)) CMV induces the expansion of CD8 + CD45RA + CD27" T cells.
FigureFigure 5 Individual set-points of stable CD8*CD45RA*CD2r T cell numbers (10 6 /ml) in pediatric kidneykidney transplant patients depend on the moment of primary CMV infection
Inn conclusion, we show that not only may CMV-specific cells preferentially have a CD8 + CD45RA + CD27"" phenotype, but, importantly, CMV is the predominant factor that determiness the presence of these T cells in peripheral blood. Age at onset of CMV infection or,, in more general terms, immunocompetence determines to a great extent the level or setpointt at which an individual's number of cytolytic cells stabilizes. The mechanism by which CMVV induces a large number of uniquely expanded CD8 + cytolytic T cells warrants further studyy as an intriguing facet of the interplay between CMV and the immune system.
